SEED ROUND CLOSES IN

Scott King President, Founder

Scott is Founder and President of Hanuman Medical, creating and patenting new medical technologies. In addition to founding and managing Islet Sheet Medical and PlasmaSeal, Scott was Wall Street’s first biotechnology industry analyst. Scott was educated at the University of Chicago (B.S.) and Harvard University (M.A.).

Mike Leach

Mike has over 20 years of experience in design, development, and operations within the medical device industry with Zimmer Biomet. Mike began his career in the aerospace industry. Mike is a co-inventor on more than 40 patents and 60+ patent applications. Mike has a B.S. degree from Grace College.

Dr. Rick Storrs

Rick has over 20 years of experience in cell biology, design, and engineering across industry and academia. Prior roles include VP R&D at Hanuman Medical, and as COO at Cerco Medical, Sr. Scientist at Plasmaseal, and Lead Scientist at DepoTech. Rick is a co-inventor of more than a dozen patented technologies and author of numerous peer-reviewed papers. Rick was trained as a protein chemist at University of California, Berkeley (PhD) and drug delivery scientist (NIH Postdoctoral Fellow, Stanford).

Randy Dorian

Randy has four decades of experience in academic and industrial research and development. He has served in senior level research positions, including EVP at Hanuman Medical, CSO at Cerco Medical, SVP at PlasmaSeal, and Sr Scientist / Director at Transtech Medical. With expertise in biotechnology, biochemistry, applied mathematics, bioengineering design and fabrication, Randy holds nearly 50 patents and has authored numerous academic papers.

Alan Gray

Alan is an experienced drug and drug device, product development, QA/QC, regulatory affairs and R&D expert, with 40+ year’s experience including in RBC testing/evaluation and manufacturing. Alan holds an MS Degree from University of Massachusetts, Lowell, in Biological Sciences (experimental haematology) and a BS Degree from University of Massachusetts, Lowell in Biological Sciences.

Dr. Matt Landrigan

Matt is an experienced Program Manager spanning Regenerative Medicine, Biotech and Medical Device R&D projects. Matt has 9 years of medical device development, 3 years of late stage drug development and 3 years of clinical strategy and execution experience. Matt holds a PhD in Biomechanical Engineering and Masters Degree in Mechanical Engineering from Notre Dame, Bachelor of Science Degree from Purdue University Fort Wayne in Mechanical Engineering.

Antony Sommerfeld Non-Executive Director

Antony is a Managing Director at AIP, a capital introduction, advisory and services firm to the Lifesciences, Commodities and AI/ML sectors. Previously Antony was a Founding Partner at Adamant Ventures, an investment fund and Co-Founder of DRS. Antony is also the Co-Founder of AI/ML Start-Up ENRGeo and Move78. He is a graduate of Imperial College London, UCL and Oxford University.